10x Genomics Inc. filed a lawsuit alleging that Vizgen Inc.’s products and lab services for its Merscope platform infringe five patents for spatial-imaging technology, which allows researchers to build “a kind of Google Earth” so they can tie a biological substance’s function to its location.
The inventions covered by the patents underpin 10x’s forthcoming Xenium In Situ platform, which is “designed to create spatial maps of gene expression in the original tissue at true cellular and subcellular resolutions,” according to a complaint filed Tuesday in the U.S. District Court for the District of Delaware.
Harvard College, a co-plaintiff, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.